Literature DB >> 27163985

Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.

Sian Taylor-Phillips1, Matthew G Wallis2, David Jenkinson1, Victor Adekanmbi1, Helen Parsons1, Janet Dunn1, Nigel Stallard1, Ala Szczepura1, Simon Gates1, Olive Kearins3, Alison Duncan4, Sue Hudson5, Aileen Clarke1.   

Abstract

IMPORTANCE: Interpreting screening mammograms is a difficult repetitive task that can result in missed cancers and false-positive recalls. In the United Kingdom, 2 film readers independently evaluate each mammogram to search for signs of cancer and examine digital mammograms in batches. However, a vigilance decrement (reduced detection rate with time on task) has been observed in similar settings.
OBJECTIVE: To determine the effect of changing the order for the second film reader of batches of screening mammograms on rates of breast cancer detection. DESIGN, SETTING, AND PARTICIPANTS: A multicenter, double-blind, cluster randomized clinical trial conducted at 46 specialized breast screening centers from the National Health Service Breast Screening Program in England for 1 year (all between December 20, 2012, and November 3, 2014). Three hundred sixty readers participated (mean, 7.8 readers per center)-186 radiologists, 143 radiography advanced practitioners, and 31 breast clinicians, all fully qualified to report mammograms in the NHS breast screening program.
INTERVENTIONS: The 2 readers examined each batch of digital mammograms in the same order in the control group and in the opposite order to one another in the intervention group. MAIN OUTCOMES AND MEASURES: The primary outcome was cancer detection rate; secondary outcomes were rates of recall and disagreements between readers.
RESULTS: Among 1,194,147 women (mean age, 59.3; SD, 7.49) who had screening mammograms (596,642 in the intervention group; 597,505 in the control group), the images were interpreted in 37,688 batches (median batch size, 35; interquartile range [IQR]; 16-46), with each reader interpreting a median of 176 batches (IQR, 96-278). After completion of all subsequent diagnostic tests, a total of 10,484 cases (0.88%) of breast cancer were detected. There was no significant difference in cancer detection rate with 5272 cancers (0.88%) detected in the intervention group vs 5212 cancers (0.87%) detected in the control group (difference, 0.01% points; 95% CI, -0.02% to 0.04% points; recall rate, 24,681 [4.14%] vs 24,894 [4.17%]; difference, -0.03% points; 95% CI, -0.10% to 0.04% points; or rate of reader disagreements, 20,471 [3.43%] vs 20,793 [3.48%]; difference, -0.05% points; 95% CI, -0.11% to 0.02% points). CONCLUSIONS AND RELEVANCE: Interpretation of batches of mammograms by qualified screening mammography readers using a different order vs the same order for the second reading resulted in no significant difference in rates of detection of breast cancer. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN46603370.

Entities:  

Mesh:

Year:  2016        PMID: 27163985     DOI: 10.1001/jama.2016.5257

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Benefits of Independent Double Reading in Digital Mammography: A Theoretical Evaluation of All Possible Pairing Methodologies.

Authors:  Patrick C Brennan; Aarthi Ganesan; Miguel P Eckstein; Ernest Usang Ekpo; Kriscia Tapia; Claudia Mello-Thoms; Sarah Lewis; Mordechai Z Juni
Journal:  Acad Radiol       Date:  2018-07-29       Impact factor: 3.173

2.  Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design.

Authors:  Ioannis Sechopoulos; Craig K Abbey; Daniëlle van der Waal; Tanya Geertse; Eric Tetteroo; Ruud M Pijnappel; Mireille J M Broeders
Journal:  Eur Radiol       Date:  2022-04-28       Impact factor: 5.315

3.  Variations in breast cancer detection rates during mammogram-reading sessions: does experience have an impact?

Authors:  Abdulaziz S Alshabibi; Moayyad E Suleiman; Salman M Albeshan; Robert Heard; Patrick C Brennan
Journal:  Br J Radiol       Date:  2021-11-04       Impact factor: 3.039

4.  Double Reading in Breast Cancer Screening: Cohort Evaluation in the CO-OPS Trial.

Authors:  Sian Taylor-Phillips; David Jenkinson; Chris Stinton; Matthew G Wallis; Janet Dunn; Aileen Clarke
Journal:  Radiology       Date:  2018-04-10       Impact factor: 11.105

5.  MicroRNA-216a suppresses the proliferation and migration of human breast cancer cells via the Wnt/β-catenin signaling pathway.

Authors:  Qing Xie; Shuai Wang; Yue Zhao; Zhenchao Zhang; Chuan Qin; Xianjun Yang
Journal:  Oncol Rep       Date:  2019-03-07       Impact factor: 3.906

Review 6.  Fatigue in radiology: a fertile area for future research.

Authors:  Sian Taylor-Phillips; Chris Stinton
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

7.  Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial.

Authors:  Nick Woznitza; Anand Devaraj; Samuel M Janes; Stephen W Duffy; Angshu Bhowmik; Susan Rowe; Keith Piper; Sue Maughn; David R Baldwin
Journal:  Trials       Date:  2017-11-06       Impact factor: 2.279

Review 8.  Errors in Mammography Cannot be Solved Through Technology Alone

Authors:  Ernest Usang Ekpo; Maram Alakhras; Patrick Brennan
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26

9.  Does it matter for the radiologists' performance whether they read short or long batches in organized mammographic screening?

Authors:  Heinrich A Backmann; Marthe Larsen; Anders S Danielsen; Solveig Hofvind
Journal:  Eur Radiol       Date:  2021-06-10       Impact factor: 5.315

10.  Optimising breast cancer screening reading: blinding the second reader to the first reader's decisions.

Authors:  Jennifer A Cooper; David Jenkinson; Chris Stinton; Matthew G Wallis; Sue Hudson; Sian Taylor-Phillips
Journal:  Eur Radiol       Date:  2021-06-12       Impact factor: 5.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.